Sanofi will cut 750 jobs in France but says it remains committed to biologic and vaccine manufacturing investments totaling €700 million ($800 million) in the country. With civil unrest breaking out on the streets of Paris as members of the so-called ‘Gilets Jaunes’ demand everything from lower taxes to better job security, France’s largest biopharma firm Sanofi has revealed plans to reduce its domestic workforce by 750, and scrap plans to recruit a further 250 staff. “Sanofi in France informed…